What Does The Strategic Industry Forecast Indicate For The Hypodermic Syringes And Needles Global Market Report 2025 Market Through 2029?
How Has The Hypodermic Syringes And Needles Global Market Report 2025 Market Performed Historically, And What Growth Trajectory Is Expected Ahead?
The hypodermic syringes and needles market size has grown marginally in recent years. It will grow from $7.01 billion in 2024 to $7.13 billion in 2025 at a compound annual growth rate (CAGR) of 1.6%. The growth in the historic period can be attributed to medical advancements, prevalence of chronic diseases, vaccination programs, growth in geriatric population, expansion of healthcare infrastructure, global health initiatives.
The hypodermic syringes and needles market size is expected to see steady growth in the next few years. It will grow to $8.58 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to growth in biologics and biosimilars, home healthcare trends, rise in diabetes cases, focus on infection control, drug delivery devices for chronic conditions, e-commerce growth in medical supplies. Major trends in the forecast period include sustainable packaging, technological advances in needle safety, pre-filled syringes and autoinjectors, telehealth and remote medication administration, strategic partnerships in manufacturing.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10336&type=smp
What Are The Main Market Drivers Shaping The Progression Of The Hypodermic Syringes And Needles Global Market Report 2025 Market?
The prevalence of chronic diseases is expected to propel the growth of hypodermic syringes and needles market going forward. The rise in chronic diseases is primarily attributed to factors such as aging populations, unhealthy lifestyles, environmental influences, and increased prevalence of risk factors like obesity and sedentary behavior. Hypodermic syringes and needles are used for administering medications, vaccines, and biological therapies to manage chronic diseases effectively, ensuring precise dosage and delivery. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based independent agency of the Australian Government that provides information and statistics on the health and welfare of Australians, in 2022, approximately 15.4 million individuals, accounting for 61%, were reported to be living with at least one of the selected long-term health conditions. Therefore, the prevalence of chronic diseases will drive the hypodermic syringes and needles market.
What Leading Segment Types Are Used To Analyze The Hypodermic Syringes And Needles Global Market Report 2025 Market?
The hypodermic syringes and needlesmarket covered in this report is segmented —
1) By Type: Syringes, Needles
2) By Usability: Disposable, Re-Usable
3) By Application: Blood Collection, Drug Delivery, Vaccination, Insulin Administration, Other Applications
4) By End-Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End-Uses
Subsegments:
1) By Syringes: Disposable Syringes, Reusable Syringes, Safety Syringes
2) By Needles: Standard Needles, Safety Needles, Prefilled Needles, Specialty Needles
Which Trend Shifts Are Redefining Opportunities In The Hypodermic Syringes And Needles Global Market Report 2025 Market?
Major companies operating in the hypodermic syringes and needles market are developing advanced innovative passive safety needles to gain a competitive edge in the market. A passive safety needle is a type of injection needle designed with an automatic safety mechanism that activates after use, effectively shielding the needle tip to prevent needlestick injuries without requiring additional actions from the healthcare professional. For instance, in January 2023, MTD Group, an Italy-based med-tech company, received FDA clearance for the DropSafe Sicura passive safety needle. This innovative injection needle is designed for intramuscular and subcutaneous administration of vaccines and other drugs, aiming to eliminate needlestick injuries among healthcare professionals (HCPs). With an automatic locking transparent shield post-injection, the DropSafe Sicura requires no additional activation, ensuring a safer injection experience.
Who Are The Core Market Contributors Recognized Within The Hypodermic Syringes And Needles Global Market Report 2025 Market Ecosystem?
Major companies operating in the hypodermic syringes and needles market include Becton Dickinson And Company, B. Braun Melsungen AG, Cardinal Health Inc., Smiths Medical Inc., Terumo Corporation, Nipro Corporation, Medline Industries LP, EXELINT International Co., Vitrex Medical A/S, Gerresheimer AG, Teleflex Incorporated, Catalent Pharma Solutions, DeRoyal Industries Inc., Hospira Inc., Owen Mumford Inc., Covidien plc, Schott AG, Codan Medizinische Geräte GmbH & Co. KG, Helapet Ltd., Vygon S.A., Medtronic plc, Argon Medical Devices Inc.
Get Your In-Depth Hypodermic Syringes And Needles Global Market Report 2025 Market Report Now:
https://www.thebusinessresearchcompany.com/report/hypodermic-syringes-and-needles-global-market-report
Which Geographical Areas Are Expected To Witness The Most Substantial Hypodermic Syringes And Needles Global Market Report 2025 Market Expansion Ahead?
North America was the largest region in the hypodermic syringes and needles market in 2024. The regions covered in the hypodermic syringes and needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment